Cargando…

Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19

BACKGROUND: Severe coronavirus disease 2019 (COVID-19) is associated with systemic hyper-inflammation. An adaptive interaction between gut microbiota and host immune systems is important for intestinal homeostasis and systemic immune regulation. The association of gut microbial composition and funct...

Descripción completa

Detalles Bibliográficos
Autores principales: Talukdar, Daizee, Bandopadhyay, Purbita, Ray, Yogiraj, Paul, Shekhar Ranjan, Sarif, Jafar, D’Rozario, Ranit, Lahiri, Abhishake, Das, Santanu, Bhowmick, Debaleena, Chatterjee, Shilpak, Das, Bhabatosh, Ganguly, Dipyaman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170741/
https://www.ncbi.nlm.nih.gov/pubmed/37161621
http://dx.doi.org/10.1186/s13099-023-00546-z
_version_ 1785039285805645824
author Talukdar, Daizee
Bandopadhyay, Purbita
Ray, Yogiraj
Paul, Shekhar Ranjan
Sarif, Jafar
D’Rozario, Ranit
Lahiri, Abhishake
Das, Santanu
Bhowmick, Debaleena
Chatterjee, Shilpak
Das, Bhabatosh
Ganguly, Dipyaman
author_facet Talukdar, Daizee
Bandopadhyay, Purbita
Ray, Yogiraj
Paul, Shekhar Ranjan
Sarif, Jafar
D’Rozario, Ranit
Lahiri, Abhishake
Das, Santanu
Bhowmick, Debaleena
Chatterjee, Shilpak
Das, Bhabatosh
Ganguly, Dipyaman
author_sort Talukdar, Daizee
collection PubMed
description BACKGROUND: Severe coronavirus disease 2019 (COVID-19) is associated with systemic hyper-inflammation. An adaptive interaction between gut microbiota and host immune systems is important for intestinal homeostasis and systemic immune regulation. The association of gut microbial composition and functions with COVID-19 disease severity is sparse, especially in India. We analysed faecal microbial diversity and abundances in a cohort of Indian COVID-19 patients to identify key signatures in the gut microbial ecology in patients with severe COVID-19 disease as well as in response to different therapies. The composition of the gut microbiome was characterized using 16Sr RNA gene sequences of genomic DNA extracted from faecal samples of 52 COVID-19 patients. Metabolic pathways across the groups were predicted using PICRUSt2. All statistical analyses were done using Vegan in the R environment. Plasma cytokine abundance at recruitment was measured in a multiplex assay. RESULTS: The gut microbiome composition of mild and severe patients was found to be significantly different. Immunomodulatory commensals, viz. Lachnospiraceae family members and Bifidobacteria producing butyrate and short-chain fatty acids (SCFAs), were under represented in patients with severe COVID-19, with an increased abundance of opportunistic pathogens like Eggerthella. The higher abundance of Lachnoclostridium in severe disease was reduced in response to convalescent plasma therapy. Specific microbial genera showed distinctive trends in enriched metabolic pathways, strong correlations with blood plasma cytokine levels, and associative link to disease outcomes. CONCLUSION: Our study indicates that, along with SARS-CoV-2, a dysbiotic gut microbial community may also play an important role in COVID-19 severity through modulation of host immune responses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13099-023-00546-z.
format Online
Article
Text
id pubmed-10170741
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101707412023-05-11 Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19 Talukdar, Daizee Bandopadhyay, Purbita Ray, Yogiraj Paul, Shekhar Ranjan Sarif, Jafar D’Rozario, Ranit Lahiri, Abhishake Das, Santanu Bhowmick, Debaleena Chatterjee, Shilpak Das, Bhabatosh Ganguly, Dipyaman Gut Pathog Research BACKGROUND: Severe coronavirus disease 2019 (COVID-19) is associated with systemic hyper-inflammation. An adaptive interaction between gut microbiota and host immune systems is important for intestinal homeostasis and systemic immune regulation. The association of gut microbial composition and functions with COVID-19 disease severity is sparse, especially in India. We analysed faecal microbial diversity and abundances in a cohort of Indian COVID-19 patients to identify key signatures in the gut microbial ecology in patients with severe COVID-19 disease as well as in response to different therapies. The composition of the gut microbiome was characterized using 16Sr RNA gene sequences of genomic DNA extracted from faecal samples of 52 COVID-19 patients. Metabolic pathways across the groups were predicted using PICRUSt2. All statistical analyses were done using Vegan in the R environment. Plasma cytokine abundance at recruitment was measured in a multiplex assay. RESULTS: The gut microbiome composition of mild and severe patients was found to be significantly different. Immunomodulatory commensals, viz. Lachnospiraceae family members and Bifidobacteria producing butyrate and short-chain fatty acids (SCFAs), were under represented in patients with severe COVID-19, with an increased abundance of opportunistic pathogens like Eggerthella. The higher abundance of Lachnoclostridium in severe disease was reduced in response to convalescent plasma therapy. Specific microbial genera showed distinctive trends in enriched metabolic pathways, strong correlations with blood plasma cytokine levels, and associative link to disease outcomes. CONCLUSION: Our study indicates that, along with SARS-CoV-2, a dysbiotic gut microbial community may also play an important role in COVID-19 severity through modulation of host immune responses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13099-023-00546-z. BioMed Central 2023-05-10 /pmc/articles/PMC10170741/ /pubmed/37161621 http://dx.doi.org/10.1186/s13099-023-00546-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Talukdar, Daizee
Bandopadhyay, Purbita
Ray, Yogiraj
Paul, Shekhar Ranjan
Sarif, Jafar
D’Rozario, Ranit
Lahiri, Abhishake
Das, Santanu
Bhowmick, Debaleena
Chatterjee, Shilpak
Das, Bhabatosh
Ganguly, Dipyaman
Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19
title Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19
title_full Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19
title_fullStr Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19
title_full_unstemmed Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19
title_short Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19
title_sort association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in indian patients with covid-19
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170741/
https://www.ncbi.nlm.nih.gov/pubmed/37161621
http://dx.doi.org/10.1186/s13099-023-00546-z
work_keys_str_mv AT talukdardaizee associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19
AT bandopadhyaypurbita associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19
AT rayyogiraj associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19
AT paulshekharranjan associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19
AT sarifjafar associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19
AT drozarioranit associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19
AT lahiriabhishake associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19
AT dassantanu associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19
AT bhowmickdebaleena associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19
AT chatterjeeshilpak associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19
AT dasbhabatosh associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19
AT gangulydipyaman associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19